Showing results (1301-1310 of 1,437) with videos related to
Sort By:
Pageof 144
Clinical Genetics|June 17, 2026
The WHO Classification of Genetic Tumour Syndromes: Considerations for GeneticsIan A Cree, Mark J Arends, Joseph D Khoury, et al.Experimental Parasitology|July 31, 2016
Diphenyl diselenide supplementation in infected mice by Toxoplasma gondii: Protective effect on behavior, neuromodulation and oxidative stress caused by diseaseVanessa Schopf Machado, Nathieli B Bottari, Matheus D Baldissera, et al.Molecular Cell|May 5, 2018
Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid Metabolism By Facilitating AutophagyMark R Lundquist, Marcus D Goncalves, Ryan M Loughran, et al.Gigascience|May 15, 2018
The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implicationsVarune Rohan Ramnarine, Mohammed Alshalalfa, Fan Mo, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 14, 2019
Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudyGeoffrey A Rubin, Ajay J Kirtane, Shmuel Chen, et al.Alcoholism, Clinical and Experimental Research|February 24, 2001
Improving alcoholism treatment across the spectrum of servicesM E Hilton, S A Maisto, J Conigliaro, et al.JCI Insight|November 3, 2018
Transcriptomic heterogeneity in multifocal prostate cancerSimpa S Salami, Daniel H Hovelson, Jeremy B Kaplan, et al.Cancer|December 22, 2017
Bone biopsy protocol for advanced prostate cancer in the era of precision medicineVerena Sailer, Marc H Schiffman, Myriam Kossai, et al.Nature Communications|September 8, 2018
Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responsesQiuhui Li, Qu Deng, Hsueh-Ping Chao, et al.Molecular Oncology|October 1, 2014
Antibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancerJintang He, Xuefei Sun, Tujin Shi, et al.Pageof 144